Real-world treatment outcomes with halobetasol propionate 0.01%/tazarotene 0.045% lotion in patients with mild-to-moderate plaque psoriasis: A Canadian multicenter retrospective chart review

Bibliographic Details
Main Authors:	Ronald Vender, MD, Irina Turchin, MD, Perla Lansang, MD, Vimal H. Prajapati, MD, Mark Legault, PhD, Maxime Barakat, MD, PhD, MBA, Jensen Yeung, MD
Format:	Article
Language:	English
Published:	Elsevier 2022-09-01
Series:	JAAD International
Subjects:	biologic corticosteroid fixed combination plaque psoriasis real-world retinoid
Online Access:	http://www.sciencedirect.com/science/article/pii/S266632872200058X

Internet